Back to Search
BARBARA KAHN, MD
MD
Endocrinology, Diabetes & Metabolism Physician
NPI: 1558300970IndividualAccepts Medicare
Specialties, Licenses & Credentials
Endocrinology, Diabetes & Metabolism PhysicianPrimary
Internal Medicine — Endocrinology, Diabetes & Metabolism
Code: 207RE0101X
56981(MA)
Education
STANFORD UNIVERSITY SCHOOL OF MEDICINE
Class of 1977
Research & Publications (20)
AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism.
PMID 16054041·Cell Metab·2005
6-review
Predictors of glyburide failure in the treatment of gestational diabetes.
PMID 16738156·Obstet Gynecol·2006
8-other
The relationship of retinol binding protein 4 to changes in insulin resistance and cardiometabolic risk in overweight black adolescents.
PMID 18783798·J Pediatr·2009
8-other
Effect of exposure to small pharmaceutical promotional items on treatment preferences.
PMID 19433701·Arch Intern Med·2009
2-rct
Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice.
PMID 19633655·Nat Med·2009
7-preclinical
Neuronal protein tyrosine phosphatase 1B deficiency results in inhibition of hypothalamic AMPK and isoform-specific activation of AMPK in peripheral tissues.
PMID 19528236·Mol Cell Biol·2009
7-preclinical
Liver-specific deletion of protein-tyrosine phosphatase 1B (PTP1B) improves metabolic syndrome and attenuates diet-induced endoplasmic reticulum stress.
PMID 19074988·Diabetes·2009
7-preclinical
Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo.
PMID 18281274·J Biol Chem·2008
7-preclinical
Deletion of cd39/entpd1 results in hepatic insulin resistance.
PMID 18567823·Diabetes·2008
7-preclinical
Decreased clearance of serum retinol-binding protein and elevated levels of transthyretin in insulin-resistant ob/ob mice.
PMID 18285525·Am J Physiol Endocrinol Metab·2008
7-preclinical
aP2-Cre-mediated expression activation of an oncogenic PLAG1 transgene results in cavernous angiomatosis in mice.
PMID 18097540·Int J Oncol·2008
7-preclinical
High circulating levels of RBP4 and mRNA levels of aP2, PGC-1alpha and UCP-2 predict improvement in insulin sensitivity following pioglitazone treatment of drug-naïve type 2 diabetic subjects.
PMID 18324929·J Intern Med·2008
8-other
Freundlich and dual Langmuir isotherm models for predicting 137Cs binding on Savannah River Site soils.
PMID 18091148·Health Phys·2008
8-other
Serum concentrations of retinol-binding protein 4 in women with and without gestational diabetes.
PMID 18437353·Diabetologia·2008
4-observational
Improved glucose homeostasis in mice with muscle-specific deletion of protein-tyrosine phosphatase 1B.
PMID 17724080·Mol Cell Biol·2007
7-preclinical
Tissue-specific alterations of glucose transport and molecular mechanisms of intertissue communication in obesity and type 2 diabetes.
PMID 17952832·Horm Metab Res·2007
6-review
Effects of genetic variation in the human retinol binding protein-4 gene (RBP4) on insulin resistance and fat depot-specific mRNA expression.
PMID 17728376·Diabetes·2007
8-other
Cathepsin L activity controls adipogenesis and glucose tolerance.
PMID 17643114·Nat Cell Biol·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 330 BROOKLINE AVE
BOSTON, MA 02215 - Phone
- (617) 667-1769
Quick Facts
- NPI
- 1558300970
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 49
- Publications
- 20
Are you this provider?
Claim Your Profile